Status:
WITHDRAWN
Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease
Lead Sponsor:
Case Comprehensive Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Malignant Mesothelioma
Eligibility:
All Genders
Brief Summary
RATIONALE: Diagnostic procedures, such as optical coherence tomography, may help find and diagnose lung cancer or precancerous cells. PURPOSE: This phase I trial is studying how well optical coherenc...
Detailed Description
OBJECTIVES: * Correlate optical coherence tomography images of the airway with airway histology. * Develop an imaging technique to detect premalignant airway epithelial changes (carcinoma in situ, dy...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Undergoing pneumonectomy or lobectomy for malignant or benign lung processes
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00733252
Start Date
April 1 2008
End Date
February 1 2011
Last Update
October 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States, 44106-5065